Hangzhou AGS MedTech Co. Ltd. A Cash Flow-to-Debt Ratio
Hangzhou AGS MedTech Co. Ltd. A cash flow-to-debt ratio. Hangzhou AGS MedTech Co. Ltd. A (688581) has a Cash Flow-to-Debt Ratio of 0.94x as of December 2025, meaning its operating cash flow of CN¥151.20 Million could theoretically repay 1% of its total liabilities (CN¥160.37 Million) in one year. Check Hangzhou AGS MedTech Co. Ltd. A cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hangzhou AGS MedTech Co. Ltd. A (2021–2025)
Cash flow-to-debt ratio of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025. Historical debt coverage capacity for Hangzhou AGS MedTech Co. Ltd. A across 5 annual periods. Check 688581 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Hangzhou AGS MedTech Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2021–2025)
Hangzhou AGS MedTech Co. Ltd. A cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for Hangzhou AGS MedTech Co. Ltd. A. For the full cash flow conversion analysis, see 688581 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | CN¥151.20 Million | CN¥160.37 Million | ▼ -54.4% |
| 2024 | 2.07x | CN¥315.80 Million | CN¥152.67 Million | ▲ +14.7% |
| 2023 | 1.80x | CN¥221.45 Million | CN¥122.83 Million | ▲ +5.6% |
| 2022 | 1.71x | CN¥156.38 Million | CN¥91.59 Million | ▲ +1.9% |
| 2021 | 1.68x | CN¥118.25 Million | CN¥70.55 Million | — |